A Phase 4 interventional study of propofol and etomidate in Induction of Anaesthesia, sponsored by T.C. ORDU ÜNİVERSİTESİ. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2014-08-13.
Sponsored by T.C. ORDU ÜNİVERSİTESİ · Phase 4, Interventional, and Prevention
The purpose of this study is to evaluate the effect of propofol, etomidate and propofol-etomidate combination on hemodynamic responses during laryngoscopy and tracheal intubation and assess the adverse effect related to this drugs.
T.C. ORDU ÜNİVERSİTESİ is the lead sponsor of 87 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: etomidate-propofol
Drug: etomidate
Drug: propofol
2,5 mg/kg
0,3 mg/kg
0,15 mg/kg etomidate + 1,25 mg/kg propofol
haemodynamic values
e.g., heart rate, blood pressure (mean arterial pressure)
Time frame: in ten minutes after intubation
adverse effect of study drugs
e.g. myoclonus, injection pain, allergy, skin rash
Time frame: within in 30 minutes drug administration
This study is completed, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
T.C. ORDU ÜNİVERSİTESİ